C1RL
Complement C1r subcomponent-like protein
Also known as: C1r-LP, C1RL_HUMAN, C1RL1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NZP8
- Gene
- C1RL
- Ensembl
- ENSG00000139178
- Chromosome
- 12
- Canonical length
- 487 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
Predicted to enable serine-type endopeptidase activity. Predicted to be involved in zymogen activation. Located in extracellular exosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
487 residues, UniProt reviewed canonical sequence.
>Q9NZP8|C1RL
1 MPGPRVWGKY LWRSPHSKGC PGAMWWLLLW GVLQACPTRG SVLLAQELPQ QLTSPGYPEP
61 YGKGQESSTD IKAPEGFAVR LVFQDFDLEP SQDCAGDSVT ISFVGSDPSQ FCGQQGSPLG
121 RPPGQREFVS SGRSLRLTFR TQPSSENKTA HLHKGFLALY QTVAVNYSQP ISEASRGSEA
181 INAPGDNPAK VQNHCQEPYY QAAAAGALTC ATPGTWKDRQ DGEEVLQCMP VCGRPVTPIA
241 QNQTTLGSSR AKLGNFPWQA FTSIHGRGGG ALLGDRWILT AAHTIYPKDS VSLRKNQSVN
301 VFLGHTAIDE MLKLGNHPVH RVVVHPDYRQ NESHNFSGDI ALLELQHSIP LGPNVLPVCL
361 PDNETLYRSG LLGYVSGFGM EMGWLTTELK YSRLPVAPRE ACNAWLQKRQ RPEVFSDNMF
421 CVGDETQRHS VCQGDSGSVY VVWDNHAHHW VATGIVSWGI GCGEGYDFYT KVLSYVDWIK
481 GVMNGKNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against C1RL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 134 nTPM
Expression across tissuesHPA
Tissue
- liver: 134 nTPM
- adrenal gland: 69 nTPM
- ovary: 48 nTPM
- blood vessel: 38 nTPM
- urinary bladder: 37 nTPM
- adipose tissue: 37 nTPM
Single-cell type
- proximal tubule cells: 47 nCPM
- papillary tip epithelial cells: 45 nCPM
- renal collecting duct principal cells: 42 nCPM
- loop of henle epithelial cells: 40 nCPM
- podocytes: 35 nCPM
- distal convoluted tubule cells: 34 nCPM
Immune cell
- neutrophil: 5.4 nTPM
- eosinophil: 4 nTPM
- basophil: 3.8 nTPM
- non-classical monocyte: 1.3 nTPM
- memory B-cell: 1.2 nTPM
- intermediate monocyte: 1.1 nTPM
Brain region
- medulla oblongata: 15 nTPM
- choroid plexus: 14 nTPM
- midbrain: 9.6 nTPM
- hypothalamus: 7.8 nTPM
- thalamus: 7.7 nTPM
- pons: 7.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.16
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.9
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads C1RL as an antibody target. Whether an autoantibody or antibody against C1RL could matter depends on whether native C1RL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
C1RL is annotated as secreted, so native C1RL circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label C1RL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...